Epigenetic remodeling in the cancer landscape can lead to mobilization of the TEs which are also ligands of innate immunity particularly of RNA via TLR3, RIG1, and MDA5 receptors, of DNA via TLR3/7/8, and cGAS (190). This evidence concerns the gene TLR3 and cancer.